8-9011582-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_153332.4(ERI1):āc.328T>Cā(p.Tyr110His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,612,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00013 ( 0 hom., cov: 33)
Exomes š: 0.00017 ( 0 hom. )
Consequence
ERI1
NM_153332.4 missense
NM_153332.4 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 7.94
Genes affected
ERI1 (HGNC:23994): (exoribonuclease 1) Enables 3'-5' exonuclease activity. Predicted to be involved in exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA). Located in cytoplasm and nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM1
In a mutagenesis_site Reduces slightly RNA-binding to the stem-loop structure; when associated with A-109. (size 0) in uniprot entity ERI1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31636554).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERI1 | NM_153332.4 | c.328T>C | p.Tyr110His | missense_variant | 3/7 | ENST00000250263.8 | NP_699163.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERI1 | ENST00000250263.8 | c.328T>C | p.Tyr110His | missense_variant | 3/7 | 1 | NM_153332.4 | ENSP00000250263.7 | ||
ERI1 | ENST00000519292.5 | c.328T>C | p.Tyr110His | missense_variant | 3/8 | 2 | ENSP00000430190.1 | |||
ERI1 | ENST00000520684.5 | n.*135T>C | non_coding_transcript_exon_variant | 4/6 | 5 | ENSP00000430651.1 | ||||
ERI1 | ENST00000520684.5 | n.*135T>C | 3_prime_UTR_variant | 4/6 | 5 | ENSP00000430651.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
20
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000112 AC: 28AN: 250634Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135532
GnomAD3 exomes
AF:
AC:
28
AN:
250634
Hom.:
AF XY:
AC XY:
17
AN XY:
135532
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000171 AC: 250AN: 1460584Hom.: 0 Cov.: 30 AF XY: 0.000165 AC XY: 120AN XY: 726606
GnomAD4 exome
AF:
AC:
250
AN:
1460584
Hom.:
Cov.:
30
AF XY:
AC XY:
120
AN XY:
726606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74454
GnomAD4 genome
AF:
AC:
20
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
12
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | The c.328T>C (p.Y110H) alteration is located in exon 3 (coding exon 3) of the ERI1 gene. This alteration results from a T to C substitution at nucleotide position 328, causing the tyrosine (Y) at amino acid position 110 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at